Thrombosis
News
AUGUSTUS: Apixaban surpassed warfarin despite prior stroke or thromboembolism
LOS ANGELES – Secondary AUGUSTUS analysis showed ACS/PCI patients with AFib plus prior stroke, TIA, or thromboembolism did better on apixaban.
News
AFib patients do best on a DOAC started 7-10 days post stroke
LOS ANGELES – Observational data hints at the best time to start oral anticoagulation in AFib patients after a cardioembolic stroke.
News
What 2019’s top five CAD trials tell us
SNOWMASS, COLO. – Triple therapy as a triple threat – a three-pronged threat to patient safety, Dr. Malcolm R. Bell says.
Clinical
DOACs for treatment of cancer-associated venous thromboembolism
Recent studies suggest DOACs may be a viable option in the treatment of malignancy-associated VTE.
News
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.
News
New ASH guideline: VTE prophylaxis after major surgery
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the...
News
Aspirin plus a DOAC may do more harm than good in some
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication...
News
Pulmonary embolism treatment teams adopted widely for complex disease
News
Smokers with PE have higher rate of hospital readmission
NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco...
Clinical
Aspirin for primary prevention reduces risk of CV events, increases bleeding
What is the association between aspirin for primary prevention and cardiovascular events and bleeding?